ConductScience.org, home

Trial · NCT03969901

Adverse events730

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersIMI/REL Age Cohort 1: Adolescents (12 to <18 Years)0100
otherAnaemiaBlood and lymphatic system disordersActive Control Age Cohort 1: Adolescents (12 to <18 Years)020
otherAnaemiaBlood and lymphatic system disordersIMI/REL Age Cohort 2: Older Children (6 to <12 Years)0310
otherAnaemiaBlood and lymphatic system disordersActive Control Age Cohort 2: Older Children (6 to <12 Years)0110
otherAnaemiaBlood and lymphatic system disordersIMI/REL Age Cohort 3: Younger Children (2 to <6 Years)1211
otherAnaemiaBlood and lymphatic system disordersActive Control Age Cohort 3: Younger Children (2 to <6 Years)080
otherAnaemiaBlood and lymphatic system disordersIMI/REL Age Cohort 4: Infants and Toddlers (3 Months to <2 Years)1151
otherAnaemiaBlood and lymphatic system disordersActive Control Age Cohort 4: Infants and Toddlers (3 Months to <2 Years)040
otherAnaemiaBlood and lymphatic system disordersIMI/REL Age Cohort 5: Neonates and Young Infants (Birth to <3 Months)080
otherAnaemiaBlood and lymphatic system disordersActive Control Age Cohort 5: Neonates and Young Infants (Birth to <3 Months)030
otherLeukopeniaBlood and lymphatic system disordersIMI/REL Age Cohort 1: Adolescents (12 to <18 Years)0100
otherLeukopeniaBlood and lymphatic system disordersActive Control Age Cohort 1: Adolescents (12 to <18 Years)020
otherLeukopeniaBlood and lymphatic system disordersIMI/REL Age Cohort 2: Older Children (6 to <12 Years)0310
otherLeukopeniaBlood and lymphatic system disordersActive Control Age Cohort 2: Older Children (6 to <12 Years)0110
otherLeukopeniaBlood and lymphatic system disordersIMI/REL Age Cohort 3: Younger Children (2 to <6 Years)2212
otherLeukopeniaBlood and lymphatic system disordersActive Control Age Cohort 3: Younger Children (2 to <6 Years)080
otherLeukopeniaBlood and lymphatic system disordersIMI/REL Age Cohort 4: Infants and Toddlers (3 Months to <2 Years)0150
otherLeukopeniaBlood and lymphatic system disordersActive Control Age Cohort 4: Infants and Toddlers (3 Months to <2 Years)040
otherLeukopeniaBlood and lymphatic system disordersIMI/REL Age Cohort 5: Neonates and Young Infants (Birth to <3 Months)080
otherLeukopeniaBlood and lymphatic system disordersActive Control Age Cohort 5: Neonates and Young Infants (Birth to <3 Months)030

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03969901/events